City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
June 29, 2017 | Katie Neith
Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.
June 13, 2017 | Samantha Bonar
Dan Rojas, 31, who has been living with HIV since 2011, is one of a handful of brave patients participating in a groundbreaking study at City of Hope that seeks a cure for AIDS.
May 16, 2017 | Abe Rosenberg
Bladder cancer is a stubborn disease. Malignant cells in the bladder frequently grow back or pop up elsewhere, even if they're removed in their earliest stages. But the City of Hope surgeons and scientists working to eradicate bladder cancer are equally stubborn.
April 20, 2017 | Samantha Bonar
A new study is aimed at helping recent cancer survivors who have ostomies. The three-year randomized controlled trial is an ostomy self-management training program that hopes to coach cancer survivors to care for their ostomies via teleconferencing.
March 22, 2017 | Travis Marshall
CAR-T cell therapy research at City of Hope is an innovative and promising approach that recruits the body’s own immune system in the fight against some of the hardest-to-treat cancers, including multiple myeloma.
December 1, 2016 | Samantha Bonar
There has been great progress made in the fight against HIV/AIDS, and continued efforts to end this global epidemic. Advances, such as anti-retroviral therapy, have revolutionized HIV treatment. Now, researchers are edging closer to the ultimate goal: a cure.
April 19, 2016 | Letisia Marquez
Aaron Kim is the first HIV patient treated as part of a new City of Hope clinical trial that will determine if a patient’s own genetically engineered bone marrow cells can safely be used to treat HIV.
December 1, 2015 | Abe Rosenberg
“We could see a functional cure for HIV in the next 5-10 years,” predicts John Zaia, M.D., a world-renowned genetic researcher and Director of the Center for Gene Therapy at City of Hope's Hematologic Malignancies and Stem Cell Transplantation Institute.